title: Ligand-induced STAT3 signaling increases at relapse and is associated with outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
authors: Division of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA amsteven@txch.org.
authors: Alexandra M
authors: AM
authors: Stevens
authors: Division of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.
authors: Marcos J
authors: MJ
authors: Ruiz
authors: Children's Oncology Group, Monrovia, CA, USA.
authors: Robert B
authors: RB
authors: Gerbing
authors: Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
authors: Todd A
authors: TA
authors: Alonzo
authors: Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
authors: Alan S
authors: AS
authors: Gamis
authors: Division of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.
authors: Michele S
authors: MS
authors: Redell
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000378:metabolism* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D008297:Male; D012008:Recurrence; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human
keywords: STAT3; acute myeloid leukemia; ligand stimulation; pediatric; relapse